E-ISSN 2277-338X | ISSN 2320-4664
|Original Research|| |
Abdominal tuberculosis: experience with RNTCP category III antitubercular therapy
Sunit K Shukla, Manoj Meena, Govind N Srivastava, Piyush Arora, Chetan B Patil, Ram N Meena.
Background: Abdominal tuberculosis as such has been put in seriously ill category III regimen because the therapy of abdominal tuberculosis throws up many challenges, especially those presenting with immune compromised and malnourished state. To accommodate all the accompanying challenges, it is prudent to keep the regimen flexible.
Objective: To study the 30- and 60-day efficacy of daily versus alternate-day self-administered therapy of abdominal tuberculosis in young adults with ileocecal tuberculosis (IC) and mesenteric tubercular lymphadenitis (ML).
Materials and Methods: This study was conducted for a duration of 2 years, starting June 2013, in an outpatient setting of a tertiary referral center in north India. Patients identified during a study of causes of functional abdominal pain syndrome (FAPS) or “only pain” presentation in gastroenterology (GI) outpatient and diagnosed as IC or ML on the basis of contrast-enhanced computerized tomography (CECT) and/or colonoscopy with ileoscopy were given daily (weight based) versus alternate-day revised national tuberculosis control program (RNTCP) category III regimen therapy in a nonrandom manner.
Result: Twelve patients of abdominal tuberculosis were identified: eight cases had IC with varying degrees of gastrointestinal disturbances whereas four had ML with no other organic disease explaining the symptoms. Groups prescribed daily versus alternate-day therapy did not differ significantly because of the presentation as FAPS in young adults. All patients received clinically significant improvement with antitubercular therapy. Four patients prescribed RNTCP category III regimen showed excellent clinical relief. Dyspepsia occurred significantly more with alternate-day therapy.
Conclusion: Self-administered DOTS alternate-day therapy according to RNTCP category III regimen is equally efficacious to daily-weight-based regimen in young adults with abdominal tuberculosis.
Abdominal, tuberculosis, DOTS, functional abdominal pain syndrome
| || |
|1. Rasheed S, Zinicola R, Watson D, Bajwa A, McDonald PJ. Intra-abdominal and gastrointestinal tuberculosis. Colorectal Dis 2007;9:773-83. [DOI via Crossref] [Pubmed] |
|2. Patel N, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, et al. Gastrointestinal luminal tuberculosis: establishing the diagnosis. J Gastroenterol Hepatol 2004;19:1240-6. [DOI via Crossref] [Pubmed] |
|3. Sinan T, Sheikh M, Ramadan S, Sahwney S, Behbehani A. CT features in abdominal tuberculosis: 20 years experience. BMC Med Imaging 2002;2:3. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|4. Sood R. Diagnosis of abdominal tuberculosis: role of imaging. J Indian Acad Clin Med 2001;2:169-177.|
|5. Sanai FM, Bzeizi KI. Systematic review: tuberculous peritonitisÂ— presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther 2005;22:685-700. [DOI via Crossref] [Pubmed] |
|6. Shah S, Thomas V, Mathan M, Chacko A, Chandy G, Ramakrishna BS, et al. Colonoscopic study of 50 patients with colonic tuberculosis. Gut 1992;33:347-51. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|7. Rajanandh MG, Nageswari AD, Ramasamy C, Dinesh V. Side effects of antitubercular drugs on directly observed treatment strategy under revised National Tuberculosis Control Programme in a teaching hospital. Global J Pharmacol 2012;6(1):29-32.|